News
Full Steam Ahead: uniQure’s On Track With Hope for Accelerated Approval of Huntington’s Disease Drug
We’ve been following the development of uniQure’s HTT-lowering drug, AMT-130, from its genesis in the lab, to animal studies just a few years ago, and now through to their ongoing Phase 1/2 clinical ...
COVID-19 update: what does it mean for HD families, how does it impact HD research, and how has it changed the way science works? Wave Life Sciences announces that its antisense drug WVE-120102 has ...
Announcing the 2025 HDBuzz Prize for Young Science Writers – sponsored by the Hereditary Disease Foundation!
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD ...
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote ...
Huntington's disease mice are fat but HD patients lose weight – is a brain area called the hypothalamus to blame?
Animal models of Huntington's disease: what they tell us about the disease and how can they help develop new therapie ...
From vision changes to genetic traffic jams and a clinical trial update, May was full of HD science excitement! Dive into our latest roundup to see how researchers are advancing Huntington’s ...
Sign up to our monthly email summary by entering your email address on our mailing list page. Is there something you want us to write about? Tell us about it here. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results